Refine
Year of publication
Document Type
- Article (45)
- Conference Proceeding (1)
- Preprint (1)
Language
- English (47)
Has Fulltext
- yes (47)
Is part of the Bibliography
- no (47)
Keywords
- mesenchymal stromal/stem cells (6)
- ataxia telangiectasia (5)
- Aspergillus fumigatus (4)
- Ataxia telangiectasia (4)
- ATM (3)
- Ataxia-telangiectasia (3)
- cystic fibrosis (3)
- lung function (3)
- primary immunodeficiency (3)
- Allergic asthma (2)
- CBA (2)
- CRP (2)
- Cytokines (2)
- IL-6 (2)
- Neurodegeneration (2)
- SD-OCT (2)
- VEGF (2)
- adipose-derived stromal/stem cells (2)
- bio imaging (2)
- bioluminescence (2)
- body plethysmography (2)
- cytokines (2)
- extracellular vesicles (2)
- hypoxia (2)
- inflammation (2)
- malignancy (2)
- qRT-PCR (2)
- tracking (2)
- Aggressive periodontitis (1)
- Albumin ratio (1)
- Ataxia score (1)
- Atm (1)
- BRVO (1)
- BV6 (1)
- Biomarker (1)
- Bronchial inflammation (1)
- C-reactive protein (1)
- CD45RA naïve lymphocytes (1)
- CRVO (1)
- CVID (1)
- Cell distribution (1)
- Cerebrospinal fluid (1)
- Chronic periodontiti (1)
- D-dimer (1)
- Disease progression (1)
- Double-blind placebo-controlled trial (1)
- European Society for Immunodeficiencies (ESID) (1)
- Exercise challenge (1)
- Exercise-induced asthma (1)
- Exhaled nitric oxide (1)
- F508del homozygous (1)
- Forced expiratory volume in 1 s (1)
- German PID-NET registry (1)
- GvHD (1)
- HSCT (1)
- HbA1c (1)
- IgA deficiency (1)
- IgE (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunodeficiency (1)
- Immunoglobulins (1)
- Immunology and Microbiology Section (1)
- Induced sputum (1)
- Interleukin-6 (1)
- Leukocyte elastase (1)
- Lipopolysaccharide-binding protein (1)
- Longchain polyunsaturated fatty acids (1)
- Lymphopenia Mortality (1)
- MCP (1)
- MCP-1 (1)
- Mortality (1)
- Neurofilament light chain (1)
- NfL (1)
- OGTT (1)
- PCR (1)
- PID prevalence (1)
- Preclinical research (1)
- Pseudomonas aeruginosa (1)
- RD cells (1)
- RH30 cells (1)
- RNA (1)
- SARS-CoV-2 (1)
- Smart nebulizer (1)
- T-lymphocytes (1)
- TNF inhibitors (1)
- Translational research (1)
- Ultrasonic nebulizer (1)
- Vitreous samples (1)
- acute kidney injury (1)
- acute lung injury (1)
- adipose tissue (1)
- asthma (1)
- ataxia score (1)
- autovaccine (1)
- basic mechanisms (1)
- bronchial allergen challenge (1)
- bronchial allergen provocation (1)
- bronchial epithelium (1)
- bronchiolitis obliterans syndrome (1)
- cancer surveillance (1)
- characterization (1)
- chronic inflammation (1)
- clinical immunology (1)
- co-infection (1)
- combined immunodeficiency (1)
- comorbidity (1)
- coronary artery disease (1)
- cyclosporin A (1)
- cytokine (1)
- cytokine(s) (1)
- cytomegalovirus (1)
- cytotoxicity (1)
- dapagliflozin (1)
- desensitization (1)
- diabetes (1)
- diabetes therapy (1)
- empagliflozin (1)
- endothelial function (1)
- epithelial cells (1)
- fat (1)
- gap junction protein alpha 4-genotype (1)
- gene expression (1)
- granulomas (1)
- granulomatous inflammation (1)
- haploidentical (1)
- hematopoietic stem cell transplantation (1)
- hepatic steatosis (1)
- house dust mite allergy (1)
- human Natural Killer cell (1)
- human natural killer cell (1)
- immune deficiency (1)
- immunologic (1)
- immunosuppressive drug (1)
- immunotherapy (1)
- inflammatory markers (1)
- injury (1)
- kidney (1)
- lipopolysaccharide (1)
- liver disease (1)
- lung disease (1)
- lung disease phenotype (1)
- mRNA (1)
- mesenchymal stromal cells (1)
- methylprednisolone (1)
- miRNA (1)
- microRNA (1)
- mycophenolic acid (1)
- natural killer cells (1)
- neurodegeneration (1)
- neutrophil elastase (1)
- non-surgical periodontal therapy (1)
- perforin (1)
- periodontal– systemic disease interactions (1)
- periodontitis (1)
- perirenal (1)
- phagocytosis (1)
- phenotype/genotype relation (1)
- pollen allergy (1)
- postinfectious bronchiolitis obliterans (1)
- pre-emptive allogeneic hematopoietic stem cell transplantation (1)
- precision medicine (1)
- preconditioning (1)
- pretreatment (1)
- primary immunodeficiency (PID) (1)
- proteomics (1)
- proximal tubule (1)
- radio sensitivity (1)
- regeneration (1)
- registry for primary immunodeficiency (1)
- renal failure (1)
- renal tubular cells (1)
- renal tubular epithelial cells (1)
- respiratory failure (1)
- respiratory infections (1)
- rhabdomyosarcoma (1)
- rhinovirus (1)
- safety (1)
- second mitochondria-derived activator of caspases mimetic (1)
- secretion (1)
- spirometry (1)
- stem cell transplantation (1)
- stem cells (1)
- stimulation (1)
- tolerability (1)
- tolerance (1)
- translatomics (1)
- vitreous samples (1)
- von Willebrand disease (1)
Institute
Ataxia telangiectasia (A-T) is a progressive and life-limiting disease associated with cerebellar ataxia due to progressive cerebellar degeneration. In addition to ataxia, which is described in detail, the presence of chorea, dystonia, oculomotor apraxia, athetosis, parkinsonism, and myoclonia are typical manifestations of the disease. The study aimed to evaluate the specificity and sensitivity of neurofilament light chain (NfL) as a biomarker of neurodegeneration in relation to SARA score. In this prospective trial, one visit of 42 A-T patients aged 1.3–25.6 years (mean 11.6 ± 7.3 years) was performed, in which NfL was determined from serum by ELISA. Additionally, a neurological examination of the patients was performed. Blood was collected from 19 healthy volunteers ≥ 12 years of age. We found significantly increased levels of NfL in patients with A-T compared to healthy controls (21.5 ± 3.6 pg/mL vs. 9.3 ± 0.49 pg/mL, p ≤ 0.01). There was a significant correlation of NfL with age, AFP, and SARA. NfL is a new potential progression biomarker in blood for neurodegeneration in A-T which increases with age.
Acute myeloid leukemia (AML) is a malignant disorder derived from neoplastic myeloid progenitor cells characterized by abnormal proliferation and differentiation. Although novel therapeutics have recently been introduced, AML remains a therapeutic challenge with insufficient cure rates. In the last years, immune-directed therapies such as chimeric antigen receptor (CAR)-T cells were introduced, which showed outstanding clinical activity against B-cell malignancies including acute lymphoblastic leukemia (ALL). However, the application of CAR-T cells appears to be challenging due to the enormous molecular heterogeneity of the disease and potential long-term suppression of hematopoiesis. Here we report on the generation of CD33-targeted CAR-modified natural killer (NK) cells by transduction of blood-derived primary NK cells using baboon envelope pseudotyped lentiviral vectors (BaEV-LVs). Transduced cells displayed stable CAR-expression, unimpeded proliferation, and increased cytotoxic activity against CD33-positive OCI-AML2 and primary AML cells in vitro. Furthermore, CD33-CAR-NK cells strongly reduced leukemic burden and prevented bone marrow engraftment of leukemic cells in OCI-AML2 xenograft mouse models without observable side effects.
Cystic fibrosis (CF) lung disease is aggravated by recurrent and ultimately chronic bacterial infections. One of the key pathogens in adult CF lung disease is P. aeruginosa (PA). In addition to bacteria, respiratory viral infections are suggested to trigger pulmonary exacerbations in CF. To date, little is known on how chronic infections with PA influence susceptibility and response to viral infection. We investigated the interactions between PA, human rhinovirus (HRV) and the airway epithelium in a model of chronic PA infection using differentiated primary bronchial epithelial cells (pBECs) and clinical PA isolates obtained from the respiratory sample of a CF patient. Cells were repeatedly infected with either a mucoid or a non-mucoid PA isolate for 16 days to simulate chronic infection, and subsequently co-infected with HRV. Key cytokines and viral RNA were quantified by cytometric bead array, ELISA and qPCR. Proteolytic degradation of IL-6 was analyzed by Western Blots. Barrier function was assessed by permeability tests and transepithelial electric resistance measurements. Virus infection stimulated the production of inflammatory and antiviral mediators, including interleukin (IL)-6, CXCL-8, tumor necrosis factor (TNF)-α, and type I/III interferons. Co-infection with a non-mucoid PA isolate increased IL-1β protein concentrations (28.88 pg/ml vs. 6.10 pg/ml), but in contrast drastically diminished levels of IL-6 protein (53.17 pg/ml vs. 2301.33 pg/ml) compared to virus infection alone. Conditioned medium obtained from co-infections with a non-mucoid PA isolate and HRV was able to rapidly degrade recombinant IL-6 in a serine protease-dependent manner, whereas medium from individual infections or co-infections with a mucoid isolate had no such effect. After co-infection with HRV and the non-mucoid PA isolate, we detected lower mRNA levels of Forkhead box J1 (FOXJ1) and Cilia Apical Structure Protein (SNTN), markers of epithelial cell differentiation to ciliated cells. Moreover, epithelial permeability was increased and barrier function compromised compared to single infections. These data show that PA infection can influence the response of bronchial epithelial cells to viral infection. Altered innate immune responses and compromised epithelial barrier function may contribute to an aggravated course of viral infection in PA-infected airways.
Autosomal recessive Ataxia Telangiectasia (A-T) is characterized by radiosensitivity, immunodeficiency and cerebellar neurodegeneration. A-T is caused by inactivating mutations in the Ataxia-Telangiectasia-Mutated (ATM) gene, a serine-threonine protein kinase involved in DNA-damage response and excitatory neurotransmission. The selective vulnerability of cerebellar Purkinje neurons (PN) to A-T is not well understood.
Background: Assessment of the effect of subgingival instrumentation (SI) on systemic inflammation in periodontitis grades B (BP) and C (CP). Methods: In this prospective cohort study, eight BP and 46 CP patients received SI. Data were collected prior to and 12 weeks after SI. Blood was sampled prior to, one day, 6, and 12 weeks after SI. Neutrophil elastase (NE), C-reactive protein (CRP), leukocyte count, lipopolysaccharide binding protein, interleukin 6 (IL-6) and IL-8 were assessed. Results: Both groups showed significant clinical improvement. NE was lower in BP than CP at baseline and 1 day after SI, while CRP was lower in BP than CP at baseline (p < 0.05). NE and CRP had a peak 1 day after SI (p < 0.05). Between-subjects effects due to CP (p = 0.042) and PISA (p = 0.005) occurred. Within-subjects NE change was confirmed and modulated by grade (p = 0.017), smoking (p = 0.029), number of teeth (p = 0.033), and PISA (p = 0.002). For CRP between-subjects effects due to BMI (p = 0.008) were seen. Within-subjects PISA modulated the change of CRP over time (p = 0.017). Conclusions: In untreated CP, NE and CRP were higher than in BP. SI results in better PPD and PISA reduction in BP than CP. Trial registration: Deutsches Register Klinischer Studien DRKS00026952 28 October 2021 registered retrospectively.
Ataxia telangiectasia (A-T) is a devastating multi-system disorder characterized by progressive cerebellar ataxia and immunodeficiency. The neurological decline may be caused by multiple factors of which ongoing inflammation and oxidative stress may play a dominant role. The objective of the present investigation was to determine cerebrospinal fluid (CSF) proteins and possible low-grade inflammation and its relation to age and neurological deterioration. In the present study, we investigated 15 patients with A-T from 2 to 16 years. Our investigation included blood and CSF tests, clinical neurological examination, A-T score, and MRI findings. The albumin ratio (AR) was analyzed to determine the blood–brain-barrier function. In addition, inflammatory cytokines (IL-1α, IL-6, IL-8, IL-12 p40, IL-17A, IFN-γ, TNF-α) were measured by the multiplex cytometric bead array. We compared the results with those from an age-matched control group. Three of the A-T patients were analyzed separately (one after resection of a cerebral meningioma, one after radiation and chemotherapy due to leukemia, one after stem cell transplantation). Patient had significantly more moderate and severe side effects due to CSF puncture (vomiting, headache, need for anti-emetic drugs) compared with healthy controls. Total protein, albumin, and the AR increased with age indicating a disturbed blood barrier function in older children. There were no differences for cytokines in serum and CSF with the exception of IL-2, which was significantly higher in controls in serum. The AR is significantly altered in A-T patients, but low-grade inflammation is not detectable in serum and CSF.
Mesenchymal stromal/stem cells and their derivates are the most promising cell source for cell therapies in regenerative medicine. The application of extracellular vesicles (EVs) as cell-free therapeuticals requires particles with a maximum regenerative capability to enhance tissue and organ regeneration. The cargo of mRNA and microRNA (miR) in EVs after hypoxic preconditioning has not been extensively investigated. Therefore, the aim of our study was the characterization of mRNA and the miR loading of EVs. We further investigated the effects of the isolated EVs on renal tubular epithelial cells in vitro. We found 3131 transcripts to be significantly regulated upon hypoxia. Only 15 of these were downregulated, but 3116 were up-regulated. In addition, we found 190 small RNAs, 169 of these were miRs and 21 were piwi-interacting RNAs (piR). However, only 18 of the small RNAs were significantly altered, seven were miRs and 11 were piRs. Interestingly, all seven miRs were down-regulated after hypoxic pretreatment, whereas all 11 piRs were up-regulated. Gene ontology term enrichment and miR-target enrichment analysis of the mRNAs and miR were also performed in order to study the biological background. Finally, the therapeutic effect of EVs on human renal tubular epithelial cells was shown by the increased expression of three anti-inflammatory molecules after incubation with EVs from hypoxic pretreatment. In summary, our study demonstrates the altered mRNA and miR load in EVs after hypoxic preconditioning, and their anti-inflammatory effect on epithelial cells.
Rationale: Postinfectious bronchiolitis obliterans (PIBO) is a rare, chronic respiratory condition, which follows an acute insult due to a severe infection of the lower airways. Objectives: The objective of this study was to investigate the long-term course of bronchial inflammation and pulmonary function testing in children with PIBO. Methods: Medical charts of 21 children with PIBO were analyzed retrospectively at the Children's University Hospital Frankfurt/Main Germany. Pulmonary function tests (PFTs) with an interval of at least 1 month were studied between 2002 and 2019. A total of 382 PFTs were analyzed retrospectively and per year, the two best PFTs, in total 217, were evaluated. Additionally, 56 sputum analysis were assessed and the sputum neutrophils were evaluated. Results: The evaluation of the 217 PFTs showed a decrease in FEV1 with a loss of 1.07% and a loss in z score of −0.075 per year. FEV1/FVC decreased by 1.44 per year. FVC remained stable, showing a nonsignificant increase by 0.006 in z score per year. However, FEV1 and FVC in L increased significantly with FEV1 0.032 L per cm and FVC 0.048 L/cm in height. Sputum neutrophils showed a significant increase of 2.12% per year. Conclusion: Our results demonstrated that in patients with PIBO pulmonary function decreased significantly showing persistent obstruction over an average follow-up period of 8 years. However, persistent lung growth was revealed. In addition, pulmonary inflammation persisted clearly showing an increasing amount of neutrophils in induced sputum. Patients did not present with a general susceptibility to respiratory infections.
Ataxia-telangiectasia (A-T) is a hereditary immune system disorder with neurodegeneration. Its first neurologic symptoms include ataxic gait in early childhood, with slowly progressive cerebellar ataxia, oculomotor apraxia, oculocutaneous telangiectasia, and progressive muscle weakness. Neonatal screening for severe T-cell deficiency was recently found to diagnose A-T patients with a significantly reduced naïve T-cell pool. Our study includes 69 A-T patients between 8 January 2002 and 1 December 2019. Nineteen cases of cancer were diagnosed in 17 patients (25%), with a median overall survival [OS; 95% cumulative indcidence (CI)] of 26·9 years for the entire cohort. The 15-year OS of 82·5% (72–95%) was significantly decreased among A-T patients with malignancies, who had a median OS of 2·11 years, with a two-year-estimated OS of 50·7% (31–82%). Haematological malignancies were the major causes of death within the initial years of life with a 15 times increased risk for death [HR (95% CI): 6·9 (3·1–15.2), P < 0·001] upon malignancy diagnosis. Male patients with A-T are at a higher cancer risk than their female counterparts. This manuscript highlights the need for cancer surveillance and prevention, as well as optimal treatment in this cohort.